Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc., trading under the ticker MAAQ on Nasdaq, is a healthcare technology company focused on AI-powered epigenetics-based testing for cardiovascular disease detection and management. The company entered the public markets through a business combination with Mana Capital Acquisition Corp, a blank-check vehicle that completed its IPO in 2021. The de-SPAC transaction closed in October 2022, and the combined entity filed its first quarterly report as a public company in November 2022. Operating within the precision medicine and molecular diagnostics segment of the healthcare sector, Cardio Diagnostics targets early identification of heart disease risk. Sign up for full data on SpacDesk to access complete filings, transaction timelines, and analytics on this and hundreds of other SPAC deals.